Pages that link to "Q28236113"
Jump to navigation
Jump to search
The following pages link to The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma (Q28236113):
Displaying 50 items.
- Osteoclasts are active in bone forming metastases of prostate cancer patients (Q21090081) (← links)
- A novel role for CCL3 (MIP-1α) in myeloma-induced bone disease via osteocalcin downregulation and inhibition of osteoblast function (Q24297354) (← links)
- Regulation of insulin secretion, glucokinase gene transcription and beta cell proliferation by adipocyte-derived Wnt signalling molecules (Q24300088) (← links)
- FGF-20 and DKK1 are transcriptional targets of beta-catenin and FGF-20 is implicated in cancer and development (Q24321511) (← links)
- CCN1/Cyr61 is regulated by the canonical Wnt signal and plays an important role in Wnt3A-induced osteoblast differentiation of mesenchymal stem cells (Q24544140) (← links)
- The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signature (Q24647037) (← links)
- Mesenchymal-epithelial interactions in the skin: increased expression of dickkopf1 by palmoplantar fibroblasts inhibits melanocyte growth and differentiation (Q24678033) (← links)
- Modulating Dickkopf-1: A Strategy to Monitor or Treat Cancer? (Q26745556) (← links)
- Wnt/β-Catenin Signaling and Disease (Q26823272) (← links)
- Immunogenic Targets for Specific Immunotherapy in Multiple Myeloma (Q26859007) (← links)
- Genetic polymorphism in extracellular regulators of Wnt signaling pathway (Q26862695) (← links)
- Management of endocrine disease: Secondary osteoporosis: pathophysiology and management (Q26998249) (← links)
- Diagnosis and treatment of bone disease in multiple myeloma: spotlight on spinal involvement (Q27011865) (← links)
- Immunotherapy strategies for multiple myeloma: the present and the future (Q27021939) (← links)
- Targeting tumor-stromal interactions in bone metastasis (Q27024561) (← links)
- The role of the BMP signaling antagonist noggin in the development of prostate cancer osteolytic bone metastasis (Q27437809) (← links)
- LRP5 and LRP6 in development and disease (Q27692072) (← links)
- Nuclear DICKKOPF-1 as a biomarker of chemoresistance and poor clinical outcome in colorectal cancer (Q27853142) (← links)
- Novel biological markers of bone: from bone metabolism to bone physiology (Q28067712) (← links)
- The insulin-like growth factor system in multiple myeloma: diagnostic and therapeutic potential (Q28075927) (← links)
- Mechanism of Action of Bortezomib and the New Proteasome Inhibitors on Myeloma Cells and the Bone Microenvironment: Impact on Myeloma-Induced Alterations of Bone Remodeling (Q28082335) (← links)
- Skeletal remodeling in health and disease (Q28235713) (← links)
- Epigenetic dysregulation of Wnt signaling pathway in multiple myeloma (Q28249838) (← links)
- Potential Role for Therapies Targeting DKK1, LRP5, and Serotonin in the Treatment of Osteoporosis (Q28256427) (← links)
- Recognizing and treating secondary osteoporosis (Q28270738) (← links)
- Gene expression profiling of B lymphocytes and plasma cells from Waldenström's macroglobulinemia: comparison with expression patterns of the same cell counterparts from chronic lymphocytic leukemia, multiple myeloma and normal individuals (Q28285016) (← links)
- Where Wnts went: the exploding field of Lrp5 and Lrp6 signaling in bone (Q28303536) (← links)
- Tgf-Beta inhibition restores terminal osteoblast differentiation to suppress myeloma growth (Q28473419) (← links)
- Computational modeling of interactions between multiple myeloma and the bone microenvironment (Q28477867) (← links)
- WIKI4, a novel inhibitor of tankyrase and Wnt/ß-catenin signaling (Q28485498) (← links)
- Dkk1 regulates ventral midbrain dopaminergic differentiation and morphogenesis (Q28508090) (← links)
- Increased osteoclastogenesis in mice lacking the carcinoembryonic antigen-related cell adhesion molecule 1 (Q28513481) (← links)
- Multi-Scale Agent-Based Multiple Myeloma Cancer Modeling and the Related Study of the Balance between Osteoclasts and Osteoblasts (Q28551480) (← links)
- Dickkopf-1 regulates bone formation in young growing rodents and upon traumatic injury (Q28584092) (← links)
- PTH stimulates bone formation in mice deficient in Lrp5 (Q28592421) (← links)
- Low-density lipoprotein receptor-related protein 5 (LRP5) mediates the prostate cancer-induced formation of new bone (Q28593008) (← links)
- Inhibition of canonical Wnt signaling increases microvascular hemorrhaging and venular remodeling in adult rats (Q30431643) (← links)
- Dickkopf homolog 1 mediates endothelin-1-stimulated new bone formation (Q30441987) (← links)
- Cancer-associated bone disease (Q30444698) (← links)
- Analysis of the expression profile of Dickkopf-1 gene in human glioma and the association with tumor malignancy (Q30478582) (← links)
- Androgen receptor-negative human prostate cancer cells induce osteogenesis in mice through FGF9-mediated mechanisms (Q30482634) (← links)
- False discovery rate control in two-stage designs (Q30528299) (← links)
- Macrophages modulate adult zebrafish tail fin regeneration (Q30581353) (← links)
- Multi-task feature selection in microarray data by binary integer programming (Q30763386) (← links)
- Increased Dickkopf-1 in Recent-onset Rheumatoid Arthritis is a New Biomarker of Structural Severity. Data from the ESPOIR Cohort (Q31038073) (← links)
- Comparison and evaluation of methods for generating differentially expressed gene lists from microarray data. (Q31050008) (← links)
- Identification of candidate genes for myeloma-induced osteocyte death based on microarray data (Q31114129) (← links)
- A robust data scaling algorithm to improve classification accuracies in biomedical data (Q31128456) (← links)
- Tumors of the osseous spine. (Q33272230) (← links)
- Gene expression analysis in human osteoblasts exposed to dexamethasone identifies altered developmental pathways as putative drivers of osteoporosis (Q33273462) (← links)